29th May 2018 15:45
29 May 2018
Cello Health plc
("Cello" or "the Company")
Director / PDMR Dealings and Total Voting Rights
The Company notifies that, on 25 May 2018, Richard Marsham and Minh Huynh, both of whom are persons discharging managerial responsibilities of the Company, exercised options over 46,000, and 15,321 ordinary shares of 10 pence each ("Shares") in the capital of the Company respectively. The new Shares will rank pari-passu with existing Shares and have been admitted to trading under the Company's existing block listing. The exercise prices paid were as follows:
Name | Number of options exercised | Exercise price paid per share (p) | Type of option scheme |
Richard Marsham | 17,428 | 42 | Approved Share Option Plan |
Richard Marsham | 16,000 | 10 | PSP Option Scheme |
Richard Marsham | 12,572 | 42 | Unapproved Option Plan |
Minh Huynh | 15,321 | 50 | Approved Option Plan |
Following the above exercise of options, Richard Marsham and Minh Huynh sold 46,000 and 15,321 Shares respectively, all at a price of 122 pence per share.
Following the issue of the new Shares, Cello's issued share capital will comprise 105,112,253 Ordinary Shares, of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 104,659,253 Ordinary Shares.
The above figure of 104,659,253 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Cello Health plc | 020 7812 8460 |
Mark Scott, Chief Executive |
|
Mark Bentley, Finance Director |
|
|
|
Cenkos Securities plc | 0207 397 8900 |
Mark Connelly Harry Hargreaves |
|
|
|
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Richard Marsham | |||
2 | Reason for the notification | ||||
a) | Position/status | PDMR and director of Cello Signal | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Options over ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | 1. Exercise of options over Ordinary Shares of 10 pence each, pursuant to Approved Share Option Plan 2. Exercise of options over Ordinary Shares of 10 pence each, pursuant to PSP Option Scheme 3. Exercise of options over Ordinary Shares of 10 pence each, pursuant to Unapproved Option Plan 4. Sale of Ordinary Shares | |||
c)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
| 1. 42p per share 2. 10p per share 3. 42p per share 4. 122p per share | 1. 17,428 2. 16,000 3. 12,572 4. 42,000 |
| |
|
|
|
|
| |
d)
| Aggregated information |
| |||
|
| ||||
- Aggregated volume | 46,000 | ||||
|
| ||||
- Price | Weighted average exercise price of 30.87p per share | ||||
|
| ||||
e)
| Date of the transaction
| 25 May 2018 | |||
f)
| Place of the transaction
| 1,2,3 - Outside trading venue 4. London Stock Exchange | |||
1
| Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Minh Huynh | |||
2 | Reason for the notification | ||||
a) | Position/status | PDMR and director of Cello Signal | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Options over ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | 1. Exercise of options over Ordinary Shares of 10 pence each, pursuant to Approved Share Option Plan 2. Sale of Ordinary Shares | |||
c)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
| 1. 50p per share 2. 122p per share | 1. 15,321 2. 15,321
|
| |
|
|
|
|
| |
d)
| Aggregated information | N/A - single transaction | |||
|
| ||||
- Aggregated volume |
| ||||
|
| ||||
- Price |
| ||||
|
| ||||
e)
| Date of the transaction
| 25 May 2018 | |||
f)
| Place of the transaction
| 1. Outside trading venue 2. London Stock Exchange | |||
About Cello Health plc
We are a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. We currently service 24 of the top 25 pharmaceutical clients globally as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.
We enable clients to differentiate their propositions and drive brand success in ever more complex global markets. We deliver our services through nearly 1,000 highly skilled professionals utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York, Philadelphia, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit: https://cellohealthplc.com/
Related Shares:
CLL.L